# National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer

> **NCT04145141** · — · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 132 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cancer
- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04145141
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-07-28
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145141, "National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04145141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*